Researcher Profiles

Christopher Belder

Adelaide Medical School

Faculty of Health and Medical Sciences

Career
Publications
Contact

Education

Date Institution name Country Title

The University of Adelaide Australia Bachelor of Medicine, Bachelor of Surgery (MBBS)
Postgraduate Training

Date Title Institution Country

Fellow of the Royal Australasian College of Physicians (FRACP) Royal Australasian College of Physicians Australia
Research Interests

Neurology & Neurosurgery Neuroscience, Behaviour and Brain Health Cognition

Journals

Year	Citation
2025	O'Connor, A., Ryan, N. S., Belder, C. R. S., Lynch, D. S., Lahiri, N., Houlden, H., . . . O'Dowd, S. (2025). Genetic testing in dementia. Practical Neurology, 25(2), 127-136. DOI Scopus1 Europe PMC1
2025	Belder, C. R. S., Boche, D., Nicoll, J. A. R., Jaunmuktane, Z., Zetterberg, H., Schott, J. M., . . . Fox, N. C. (2025). Amyloid-related iatrogenic atrophy of the brain: data transparency is an urgent safety priority – Authors' reply. The Lancet Neurology, 24(3), 190. DOI
2025	Rosa-Grilo, M., Chughtai, H. R., Thomas, D. L., Alexander, D. C., Beament, M., Belder, C. R. S., . . . Fox, N. C. (2025). Ultra-fast MRI for dementia diagnosis and treatment eligibility: A prospective study. Alzheimer S and Dementia, 21(6), e70341. DOI Europe PMC1
2024	Belder, C. R. S., Marshall, C. R., Jiang, J., Mazzeo, S., Chokesuwattanaskul, A., Rohrer, J. D., . . . Warren, J. D. (2024). Primary progressive aphasia: six questions in search of an answer. Journal of Neurology, 271(2), 1028-1046. DOI Scopus16 Europe PMC17
2024	Arber, C., Belder, C. R. S., Tomczuk, F., Gabriele, R., Buhidma, Y., Farrell, C., . . . Wray, S. (2024). The presenilin 1 mutation P436S causes familial Alzheimer's disease with elevated Aβ43 and atypical clinical manifestations. Alzheimer's and Dementia, 20(7), 4717-4726. DOI Scopus2 Europe PMC2
2024	Belder, C. R. S., Boche, D., Nicoll, J. A. R., Jaunmuktane, Z., Zetterberg, H., Schott, J. M., . . . Fox, N. C. (2024). Brain volume change following anti-amyloid β immunotherapy for Alzheimer's disease: amyloid-removal-related pseudo-atrophy. Lancet Neurology, 23(10), 1025-1034. DOI Scopus15 Europe PMC17
2023	Belder, C. R. S., Schott, J. M., & Fox, N. C. (2023). Insight Preparing for disease-modifying therapies in Alzheimer's disease. Lancet Neurology, 22(9), 782-783. DOI Europe PMC29
2023	Belder, C. R. S., Chokesuwattanaskul, A., Marshall, C. R., Hardy, C. J. D., Rohrer, J. D., & Warren, J. D. (2023). The problematic syndrome of right temporal lobe atrophy: Unweaving the phenotypic rainbow. Frontiers in Neurology, 13, 1082828-1-1082828-6. DOI Scopus10 Europe PMC11

Preprint

Year	Citation
2024	Llorente-Saguer, I., Gabriele, R., Bradshaw, T., Leckey, C. A., Belder, C. R. S., Chávez-Gutiérrez, L., . . . Arber, C. (2024). Unbiased data-driven analysis of five amyloid-beta peptides for biomarker investigations in familial Alzheimer’s disease. DOI

Email: christopher.belder@adelaide.edu.au

Connect With Me

External Profiles